A survey of the clinical use of SeHCAT in the UK

Nuclear Medicine Communications

Volumn 34, Issue 4, 2013, Pages 306-313

  Smith, Michael J ^a   Perkins, Alan C ^b,c  

^a Rotherham NHS Foundation Trust   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NIHR NOTTINGHAM BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

bile acid malabsorption; bile acids; diarrhoea; SeHCAT

Indexed keywords

TAUROSELCHOLIC ACID SE 75;

CALCULATION; GAMMA CAMERA; HUMAN; RADIODIAGNOSIS; REVIEW; SEMI STRUCTURED INTERVIEW; UNITED KINGDOM; WORKLOAD;

GREAT BRITAIN; HUMANS; NUCLEAR MEDICINE; QUESTIONNAIRES; REFERENCE VALUES; TAUROCHOLIC ACID; TIME FACTORS;

EID: 84874936169     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835e8989     Document Type: Review

References (21)

1. Boyd GS, Merrick MV, Monks R, Thomas I. Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. J Nucl Med 1981; 22:720-725.
2. Merrick MV, Eastwood MA, Anderson JR, Ross HM. Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT). J Nucl Med 1982; 23:126-130.
3. Hames TK, Condon BR, Fleming JS, Phillips G, Holdstock G, Smith CL, et al. A comparison between the use of a shadow shield whole-body counter and an uncollimated gamma camera in the assessment of the seven-day retention of SeHCAT. Br J Radiol 1984; 57:581-584.
4. Hinton PJ, Taylor DN, Wyke RJ, McLntosh JA. Application of different counting systems in measuring localised retention in the entero-hepatic circulation. Br J Radiol 1984; 57:799-801.
5. GE Healthcare. Healthcare Professional Information. SeHCAT(TM) 370 kBq Capsules, 2011.
6. Notghi A, O'Brien J, Low CS, Thomson W. Measuring SeHCAT retention: a technical note. Nucl Med Commun 2011; 32:960-966.
7. Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J (Clin Res Ed) 1985; 290:665-668.
8. Williams AJ, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption-a review of clinical presentation, diagnosis, and response to treatment. Gut 1991; 32:1004-1006.
9. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JRF, Andreyev HJN. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30:707-717.
10. Khalid U, Lalji A, Stafferton R, Andreyev J, Wedlake L, Thomas K, et al. Bile acid malabsoption: a forgotten diagnosis? Clin Med 2010; 10: 124-126.
11. Arasaradnam RP, Cullis J, Nwokolo C, Bardhan K, Williams N. Bile acid malabsorption and SeHCAT: the 'Cinderella' will be going to the Nuclear Medicine Ball! Nucl Med Commun 2012; 33:449-451.
12. Thomas PD, Forbes A, Green J, Howdle P, Long R, Playford R, et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 2003; 52 (Suppl 5):v1-v15.
13. Kurien M, Evans KE, Leeds JS, Hopper AD, Harris A, Sanders DS. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand J Gastroenterol 2011; 46:818-822.
14. Holmes R, Hayat J, Irwin A, Heenan S, Kang JY, Poullis A. Review of SeHCAT use at St Georges 2005-2010: an underutilised investigation? Gastroenterol Today 2012; 22:13-15.
15. Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009; 7:1189-1194.
16. Walters JRF. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. Expt Rev Gastroenterol Hepatol 2010; 4:561-567.
17. Johnston I, Nolan J, Pattni S, Walters J. New insights into bile acid malabsorption. Curr Gastroenterol Reports 2011;1-8.
18. Martin-Comin J, Guardiola J. Measuring SeHCAT retention: the use of a collimated gamma camera. Nucl Med Commun 2012; 33:521.
19. Notghi A, O'Brien J, Low CS, Thomson W. Response letter to 'measuring SeHCAT retention: the use of a collimated gamma camera'. Nucl Med Commun 2012; 33:522.
20. 75selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis: Kleijnen Systematic Reviews Ltd. in collaboration with Erasmus University Rotterdam and Maastricht University; 2012. Available at: http://www.nice.org.uk/nicemedia/live/13565/ 60098/60098.PDF [Accessed 18 January 2013].
21. 75selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss (Diagnostics Guidance in Development) 2012. Available at: http://guidance.nice.org.uk/DT/8 [Accessed 18 January 2013].